Paid Clinical Trials in Washington D.C., DC
As of September 2026, 842 paid clinical trials are recruiting in Washington D.C., District of Columbia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Washington D.C. offers studies at sites including MedStar Washington Hospital Center for conditions such as Breast Cancer, Sickle Cell Disease, Stroke, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Washington D.C.
Trials by drug in Washington D.C.
Filter results
Newly added in Washington D.C.
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Impact of AI Care Summaries on Caregiver Comprehension
Hinge vs CCK Implants
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Hard Cervical Collar Use Following Posterior Cervical Fusion
Feasibility of Remote Monitoring of Patients With Myasthenia Gravis
757 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Top Research Study Locations in Washington D.C.
Researchers run research studies in Washington D.C., DC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| MedStar Washington Hospital Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 97 |
| Children's National Hospital | Sickle Cell Disease, Medulloblastoma Recurrent, Asthma in Children | 86 |
| Children's National Medical Center | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Neuroblastoma | 86 |
| MedStar Georgetown University Hospital | Malignant Solid Neoplasm, Breast Cancer, Acute Myeloid Leukemia | 71 |
| Sibley Memorial Hospital | Bladder Cancer, Breast Cancer, Brain Tumor | 44 |
| Georgetown University | Alzheimer Disease, Amyotrophic Lateral Sclerosis, HIV | 39 |
| Georgetown University Medical Center | Breast Cancer, Locally Advanced Solid Tumor, Metastatic Solid Tumor | 34 |
| George Washington University | HIV Infection, Advanced Solid Tumor, Advanced Solid Tumors | 18 |
| George Washington University Medical Center | Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma | 17 |
| Children's National Health System | Anesthesia, Atopy, Autoimmunity | 11 |
| Georgetown Lombardi Comprehensive Cancer Center | Solid Tumor, Acute Myeloid Leukemia (AML) in Remission, Adenocarcinoma of Biliary Tract | 11 |
| Kaiser Permanente-Capitol Hill Medical Center | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8, Breast Cancer | 10 |
| Washington Hospital Center | AIDS, Acute or Chronic Coronary Artery Disease, Aortic Valve Disease | 9 |
| MedStar Health Research Institute | Cancer, Cancer Pain, Central Line Associated Blood Stream Infections (CLABSI) | 9 |
| Childrens National Medical Center | Chronic Graft-versus-host-disease, Genetic Disease, Lymphatic Malformations | 7 |
| Washington DC VA Medical Center, Washington, DC | Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD), BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2 | 7 |
| MedStar National Rehabilitation Hospital | Lower Urinary Tract Disorder, Multiple Sclerosis, Neurogenic Bladder | 7 |
| GSK Investigational Site | HIV Infections, Gastrointestinal Neoplasms, Multiple Myeloma | 6 |
| Georgetown University Hospital | Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Parkinson's Disease | 6 |
| MedStar Health | Acute DVT of Lower Extremity, Acute Limb Ischemia, Arterial Embolism and Thrombosis | 6 |
| Childrens National Hospital | Chronic Graft-versus-host-disease, Ewing Sarcoma, Familial Hypercholesterolemia - Heterozygous | 5 |
| Clinical Trial Site | AQP4+ NMOSD, Atypical Hemolytic-Uremic Syndrome, Generalized Myasthenia Gravis | 5 |
| George Washington University Hospital | Abdominal Compartment Syndrome, Acute Kidney Injury, Atrial Fibrillation | 5 |
| The George Washington University | Gestational Diabetes Mellitus in Pregnancy, Glucose Intolerance During Pregnancy, Metastatic Head-and-neck Squamous-cell Carcinoma | 5 |
| Children's National | Ablation, Becker Muscular Dystrophy, Cardiomyopathy | 4 |
Active & Upcoming Studies in Washington D.C. (2026)
Recruiting trials in Washington D.C. grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (289 active studies)
- A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma · Phase 3 · AbbVie
- A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer · Phase 1 · TerSera Therapeutics LLC
Neurology & pain (62 active studies)
- COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" · Phase 3 · Yale University
- Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD · EARLY_Phase 1 · Medstar Health Research Institute
Cardiovascular (50 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) · VA Office of Research and Development
Diabetes & metabolic (25 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
HIV / STI (22 active studies)
- Decision Support Tool to Integrate PrEP Into Emergency Departments · Phase 1 · George Washington University
- Study of GS-0415 and How It Works in People With HIV · Phase 1 · Gilead Sciences
Pediatric (18 active studies)
- Optimizing Pain Treatment in Children On Mechanical Ventilation · Phase 3 · Weill Medical College of Cornell University
- Pediatric Radiation Therapy Registry · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mental health & behavior (16 active studies)
- ChatGPT-Supported Text Messaging Program for Smoking Cessation · George Washington University
- Psychological Trauma, Post-Traumatic Stress Disorder, and Resilience in Adults With Congenital Heart Disease · Dartmouth-Hitchcock Medical Center
Vaccines (6 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Eye & vision (1 active study)
- The Myelin Disorders Biorepository Project · Children's Hospital of Philadelphia
Common conditions studied in Washington D.C.
- Breast Cancer (13 active studies)
- Sickle Cell Disease (12 active studies)
- Stroke (11 active studies)
- Heart Failure (9 active studies)
- Prostate Cancer (9 active studies)
- Solid Tumor (9 active studies)
Leading research sponsors in Washington D.C.
- Children's National Research Institute
- Georgetown University
- National Cancer Institute (NCI)
- George Washington University
- Medstar Health Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Washington D.C.?
There are approximately 842 recruiting clinical trials in Washington D.C., District of Columbia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Washington D.C. pay participants?
Most recruiting trials in Washington D.C. compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Washington D.C.?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Washington D.C.?
The most common conditions under active study in Washington D.C. include Breast Cancer (13), Sickle Cell Disease (12), Stroke (11), Heart Failure (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Washington D.C.?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Washington D.C. on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Washington D.C.?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Washington D.C.?
Recruiting research sites in Washington D.C. include MedStar Washington Hospital Center, Children's National Hospital, Children's National Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Washington D.C. right now?
The largest active categories in Washington D.C. are Cancer & tumors (289), Neurology & pain (62), Cardiovascular (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.